OVID Smart Money
Ovid Therapeutics Inc.
1W: -4.2%
1M: -8.1%
3M: -1.3%
YTD: +28.4%
1Y: +38.6%
3Y: -34.9%
5Y: -37.6%
$2.26
+0.10 (+4.87%)
Pre-Market: $2.35 (+0.09, +3.98%)
Weekly Expected Move ±9.9%
$2
$2
$2
$2
$3
Credit Risk of going bust: lower than 54% of companies Debt: 2.8% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.01 (down 99.6%), Ovid Therapeutics Inc. would be worth roughly what it owes.
Total debt $12.7M against a stock market value of $441.4M.
Distance to default 5.51 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $6.4M (short-term plus half of long-term), stock volatility 74.2%; Altman Z'' 7.19. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.01 (down 99.6%), Ovid Therapeutics Inc. would be worth roughly what it owes.
Total debt $12.7M against a stock market value of $441.4M.
Distance to default 5.51 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $6.4M (short-term plus half of long-term), stock volatility 74.2%; Altman Z'' 7.19. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026149
Institutions Holding
+37 vs prior
89.8%
Ownership
+36.96%
47
New
33
Increased
45
Reduced
18
Closed
👔 Insider Trades
10 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-06 | Carter Charles Ross | officer: chief financial officer | A-Grant/Award | 50,000 | $— | $0 | Filing |
| 2026-04-07 | PAPADOPOULOS STELIOS | director | A-Grant/Award | 17,578 | $2.56 | $45K | Filing |
| 2026-04-07 | Friedman Bart | director | A-Grant/Award | 8,789 | $2.56 | $22K | Filing |
| 2026-04-07 | Fitzgerald Kevin Joseph | director | A-Grant/Award | 17,578 | $2.56 | $45K | Filing |
| 2026-02-26 | Rona Jeffrey A | officer: cbfo | A-Grant/Award | 68,125 | $— | $0 | Filing |
| 2026-02-23 | ALEXANDER MARGARET A. | officer: president and ceo | S-Sale | 11,656 | $1.45 | $17K | Filing |
| 2026-02-23 | Rona Jeffrey A | officer: cbfo | S-Sale | 8,541 | $1.45 | $12K | Filing |
| 2025-12-15 | LEVIN JEREMY M | officer: ceo | C-Conversion | 71,000 | $— | $0 | Filing |
| 2025-12-08 | TAKEDA PHARMACEUTICAL CO LTD | 10% owner | C-Conversion | 1,250,000 | $— | $0 | Filing |
| 2025-12-08 | Takeda Pharmaceuticals U.S.A., Inc. | 10% owner | C-Conversion | 1,250,000 | $— | $0 | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| Jupiter Topco LLC | 20,741,234 | $56M | +20,741,234 | 2026-06-30 | Filing |
| EVENTIDE ASSET MANAGEMENT, LLC | 11,812,241 | $32M | +1,895,330 | 2026-06-30 | Filing |
| BlackRock, Inc. | 10,823,480 | $29M | +9,290,197 | 2026-06-30 | Filing |
| RA CAPITAL MANAGEMENT, L.P. | 10,500,968 | $28M | -213,032 | 2026-06-30 | Filing |
| Affinity Asset Advisors, LLC | 10,144,562 | $27M | -491,756 | 2026-06-30 | Filing |
| STATE STREET CORP | 7,900,765 | $21M | +7,380,482 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 7,760,114 | $21M | +2,501,868 | 2026-06-30 | Filing |
| ADAR1 Capital Management, LLC | 7,417,479 | $20M | +2,873,366 | 2026-06-30 | Filing |
| Balyasny Asset Management L.P. | 6,719,076 | $18M | +1,186,003 | 2026-06-30 | Filing |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 6,163,781 | $17M | — | 2026-06-30 | Filing |
| FEDERATED HERMES, INC. | 5,951,666 | $16M | +2,380,666 | 2026-06-30 | Filing |
| BRAIDWELL LP | 5,919,464 | $16M | +5,919,464 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 4,072,653 | $11M | +2,754,562 | 2026-06-30 | Filing |
| SILVERARC CAPITAL MANAGEMENT, LLC | 3,101,129 | $8M | +2,101,129 | 2026-06-30 | Filing |
| STEMPOINT CAPITAL LP | 2,417,283 | $7M | +2,417,283 | 2026-06-30 | Filing |
| Ikarian Capital, LLC | 2,269,704 | $6M | -625,000 | 2026-06-30 | Filing |
| Point72 Asset Management, L.P. | 1,945,727 | $5M | +625,117 | 2026-06-30 | Filing |
| SPHERA FUNDS MANAGEMENT LTD. | 1,353,000 | $4M | -269,828 | 2026-06-30 | Filing |
| NORTHERN TRUST CORP | 1,246,139 | $3M | +991,335 | 2026-06-30 | Filing |
| VANGUARD FIDUCIARY TRUST CO | 1,140,753 | $3M | +447,497 | 2026-06-30 | Filing |